World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
85
Citations
28956
World Ranking
1308
National Ranking
50

Medicine

D-Index
85
Citations
28956
World Ranking
14526
National Ranking
558

Overview

Marina Noris is affiliated with the Mario Negri Institute for Pharmacological Research in Italy. Their research predominantly focuses on medicine, with significant contributions in immunology and microbiology. Within these domains, their work emphasizes immunology, nephrology, and hematology, alongside studies related to infectious diseases and genetics.

The scientist has concentrated on several main topics in their research, including:

  • Complement system in diseases
  • Renal diseases and glomerulopathies
  • Blood groups and transfusion
  • SARS-CoV-2 and COVID-19 research
  • Platelet disorders and treatments
  • COVID-19 clinical research studies
  • Blood coagulation and thrombosis mechanisms

Marina Noris has published extensively in several prominent academic venues. The most frequent outlets include:

  • Kidney International
  • Frontiers in Immunology
  • Kidney International Reports
  • Zenodo (CERN European Organization for Nuclear Research)
  • Journal of the American Society of Nephrology

Among their recent papers are:

  • The case of complement activation in COVID-19 multiorgan impact, 2020, Kidney International
  • The state of complement in COVID-19, 2021, Nature Reviews. Immunology
  • Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group, 2020, Blood
  • Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice, 2021, Nephrology Dialysis Transplantation
  • The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, 2024, Kidney International

The scientist collaborates frequently with several other researchers, including:

  • Giuseppe Remuzzi
  • Ariela Benigni
  • Roberta Donadelli
  • Elena Bresin
  • Rossella Piras

Best Publications

  • Atypical Hemolytic–Uremic Syndrome

    Marina Noris;Giuseppe Remuzzi

  • Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype

    Marina Noris;Jessica Caprioli;Elena Bresin;Chiara Mossali

  • Overview of complement activation and regulation.

    Marina Noris;Giuseppe Remuzzi

  • Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome.

    Jessica Caprioli;Marina Noris;Simona Brioschi;Gaia Pianetti

  • Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

  • Hemolytic Uremic Syndrome

    Marina Noris;Giuseppe Remuzzi

  • Nitric Oxide Synthesis by Cultured Endothelial Cells Is Modulated by Flow Conditions

    Marina Noris;Marina Morigi;Roberta Donadelli;Sistiana Aiello

  • Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura

    Piero Ruggenenti;Marina Noris;Giuseppe Remuzzi

  • Thrombomodulin mutations in atypical hemolytic-uremic syndrome.

    Mieke Delvaeye;Marina Noris;Astrid De Vriese;Charles T. Esmon

  • Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells.

    Federica Casiraghi;Nadia Azzollini;Paola Cassis;Barbara Imberti

  • STEC-HUS, atypical HUS and TTP are all diseases of complement activation

    Marina Noris;Federica Mescia;Giuseppe Remuzzi

  • The state of complement in COVID-19

    Unknown

  • Mechanisms of Disease: pre-eclampsia

    Marina Noris;Norberto Perico;Giuseppe Remuzzi

  • Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical Phenotype

    Elena Bresin;Erica Rurali;Jessica Caprioli;Pilar Sanchez-Corral

  • Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome

    Tamara Manuelian;Jens Hellwage;Seppo Meri;Jessica Caprioli

  • C3 glomerulopathy — understanding a rare complement-driven renal disease

    Richard J.H. Smith;Gerald B. Appel;Anna M. Blom;H. Terence Cook

  • Familial haemolytic uraemic syndrome and an MCP mutation.

    Marina Noris;Simona Brioschi;Jessica Caprioli;Marta Todeschini

  • Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

    Marina Noris;Miriam Galbusera;Sara Gastoldi;Paolo Macor

  • Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease

    Jessica Caprioli;Federica Castelletti;Sara Bucchioni;Paola Bettinaglio

  • Autologous Mesenchymal Stromal Cells and Kidney Transplantation: A Pilot Study of Safety and Clinical Feasibility

    Norberto Perico;Federica Casiraghi;Martino Introna;Eliana Gotti

  • The Molecular Basis of Familial Hemolytic Uremic Syndrome: Mutation Analysis of Factor H Gene Reveals a Hot Spot in Short Consensus Repeat 20

    Jessica Caprioli;Paola Bettinaglio;Peter F. Zipfel;Barbara Amadei

  • The case of complement activation in COVID-19 multiorgan impact.

    Marina Noris;Ariela Benigni;Giuseppe Remuzzi

  • Natural versus adaptive regulatory T cells.

    Linda Cassis;Sistiana Aiello;Marina Noris

  • ATYPICAL HEMOLYTIC UREMIC SYNDROME AND C3 GLOMERULOPATHY: CONCLUSIONS FROM A «KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES» (KDIGO) CONTROVERSIES CONFERENCE

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

Frequent Co-Authors

Giuseppe Remuzzi
Giuseppe Remuzzi Mario Negri Institute for Pharmacological Research
Ariela Benigni
Ariela Benigni Mario Negri Institute for Pharmacological Research
Norberto Perico
Norberto Perico Mario Negri Institute for Pharmacological Research
Timothy H.J. Goodship
Timothy H.J. Goodship Newcastle University
Piero Ruggenenti
Piero Ruggenenti Mario Negri Institute for Pharmacological Research
Santiago Rodríguez de Córdoba
Santiago Rodríguez de Córdoba Spanish National Research Council
Carla Zoja
Carla Zoja Mario Negri Institute for Pharmacological Research
Peter F. Zipfel
Peter F. Zipfel Friedrich Schiller University Jena

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Advanced nursing degrees, such as a Doctor of Nursing Practice (DNP), offer specialized knowledge and increased earning potential. Understanding how much do dnps make helps prospective students gauge the financial benefits of this career path across different states.

Nurses aiming to deepen their expertise might consider shifting roles, like transitioning from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner (ACNP). Insights on fnp to acnp transitions provide guidance on educational and certification requirements for these specialized careers.

For those looking to accelerate their path, an accelerated fnp program online offers a streamlined route to becoming a Family Nurse Practitioner, addressing the growing demand for primary care providers.

Additionally, many online nursing programs cater to beginners without nursing backgrounds. Exploring online nursing programs for non nurses can help aspiring healthcare professionals start their journey in nursing and immunology.

Best Scientists Citing Marina Noris

Trending Scientists

Recently Published Articles